FdaApplication
ANDA 216901
Identifiers
- fda_app_no: ANDA216901
Properties
| Property | Value |
|---|---|
| applicant_name | XIAMEN LP PHARMACUETICAL CO LTD |
| application_type | ANDA |
| approval_date | 2025-07-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;14MG | CAPSULE, EXTENDED RELEASE;ORAL |
| MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE | DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE | 10MG;28MG | CAPSULE, EXTENDED RELEASE;ORAL |
2 products